INTRODUCTION {#SEC1}
============

A large number of organometallic transition metal-based complexes have been designed and researched ever since certain platinum complexes were found to be anti-cancer drugs by forming adducts with DNA ([@B1]). The use of large, planar aromatic systems as DNA intercallators has been well established in chemical and biological studies of DNA and related systems, and dipyrido\[3,2-a:2′,3′-c\]phenazine (dppz) has become a standard ligand in the design of metallo-intercallators ([@B9]). Ru(II) polypyridyl complexes have unique photophysical properties including intense luminescence, large Stokes shifts, red emission wavelengths and a good photostability ([@B9],[@B10]), which make them potentially invaluable for applications in cellular imaging, photochemotherapy, photoswitching, solar energy conversion and photocatalysis ([@B11]). In the field of luminescent dppz complexes for DNA binding studies, Ru(II) polypyridyl complexes with the general formula \[Ru(N^∧^N)~2~(dppz)\]Cl~2~ have been widely applied and studied both experimentally and theoretically due to their strong interactions with DNA ([@B1],[@B2],[@B16]). Due to complex modulation of the nature of the excited states, it is possible to achieve up to 10^4^ enhancement of emission intensity upon DNA binding compared to the free aqueous species ([@B19]), which is advantageous for use in fluorescence microscopy.

While there are many studies on the applications of such Ru--dppz complexes, the application in live-cell DNA imaging is rare, due to complications relating to cellular uptake and distribution of such species ([@B16]). With the characteristic for living cell uptake seemingly established ([@B17]), numerous studies aimed at effecting membrane permeability by increasing hydrophobicity through hydrophobic ligands, such as DIP (4, 7-diphenyl-1, 10-phenanthroline), or by the addition of alkyl chains or cell penetrating units (e.g. polyarginines) ([@B16],[@B17],[@B21],[@B22]), which are more 'lipid-like' in nature, have been carried out. However, while change in hydrophobicity can modulate cellular uptake, it can also affect cellular localization of these complexes and can often lead to a decrease in nuclear targeting, which will limit their applicability as *in vivo* DNA probes.

Lipophilicity has been considered to be responsible for the cellular uptake of Ru(II) polypyridyl complexes ([@B16],[@B17]). During our study on the mechanism of synergistic biochemical and toxicological effects between organic and inorganic compounds (especially transition metal complexes) ([@B24]), we found recently, that nuclear uptake of the cell-impermeable Ru(II)-polypyridyl complexes such as \[Ru(bpy)~2~(dppz)\]Cl~2~ was remarkably enhanced by pentachlorophenol (PCP) and two other biochemical agents, by forming lipophilic and relatively stable ion-pairing complexes via a passive diffusion mechanism ([@B33]). However, it is not clear whether the enhanced nuclear uptake of \[Ru(bpy)~2~(dppz)\]^2+^ is only limited to PCP, or it is a general phenomenon for other highly chlorinated phenols (HCPs) as well; and if so, what are the major physicochemical factors in determining nuclear uptake? In this study, we found that the cellular and nuclear uptake of \[Ru(bpy)~2~(dppz)\]^2+^ can also be facilitated by two other groups of HCPs including three tetrachlorophenols (TeCPs) and six trichlorophenols (TCPs). Interestingly and unexpectedly, the most effective nuclear uptake of Ru was facilitated by 2,3,4,5-TeCP, one of the three less chlorinated TeCP isomers, not by the most highly chlorinated PCP. Further studies showed that the efficiency in facilitating cellular uptake of Ru(II)-dppz complexes for HCPs was positively correlated with the binding ability, but to our surprise, inversely correlated with the lipophilicity of the ion-pairing complexes formed between \[Ru(bpy)~2~(dppz)\]Cl~2~ and HCPs. These findings may have important implications in future investigations on delivering other bio-active metal complexes into their intended cellular targets via ion-pairing method.

MATERIALS AND METHODS {#SEC2}
=====================

Chemicals {#SEC2-1}
---------

The \[Ru(bpy)~2~(dppz)\]Cl~2~ (Scheme [1](#F1){ref-type="fig"}) complex was synthesized according to ([@B34]). HCPs were purchased from Sigma.

![Chemical structures of three groups of highly chlorinated phenols (HCPs); PCP: pentachlorophenol; TeCPs: tetrachlorophenols; TCPs: trichlorophenols.](gkz152fig5){#F1}

Cell culture {#SEC2-2}
------------

HeLa cells were cultured in Dulbecco's modified Eagle's medium (DMEM) medium with 10% fetal bovine serum and 1% penicillin-streptomycin, at 37°C under a 5% CO~2~ atmosphere. Cells for confocal imaging were seeded on round coverslips at a density of ∼100 000 cells/coverslip and cultured for 1 day.

Partitioning study {#SEC2-3}
------------------

Organic solvent (n-octanol)/aqueous (Tris--HCl buffer,10 mM, pH 7.4) phase partition for Ru(II) complexes in the presence or absence of bio-chemical agents, were conducted using the 'shake-flask' method, with the concentration in each phase determined by UV-vis absorbance (Beckman DU-800).

Flow cytometry {#SEC2-4}
--------------

HeLa cells were detached from monolayer culture with trypsin, re-suspended in medium with serum and diluted to 1 × 10^6^ cells/ml. The complex \[Ru(bpy)~2~(dppz)\]Cl~2~ (100 μM) and HCPs (300 μM) were added to the cells, successively. The cells were isolated by centrifugation and rinsed with cold phosphate buffered saline (PBS) for three times. Flow cytometry was performed on a BD FACS Caliber using ∼20 000 cells per sample. Luminescence data were obtained by excitation of 488 nm with emission at 600--630 nm for Ru(II) complexes.

Confocal laser scanning microscopy {#SEC2-5}
----------------------------------

After incubated with the Ru(II) complex and chlorinated phenols, cells were rinsed with PBS for three times, and were luminescently imaged on a confocal laser scanning microscopy (CLSM) using 40× oli-immersion lens for slide imaging. The imaging was excited with 488 nm and emission was monitored at 600--630 nm. All cells were washed with PBS before imaging. Microscopy was performed on a Leica TCS SP5 CLSM. Live cells were distinguished by their low To-Pro-3 emission with excitation at 633 nm and observation at 650--670 nm.

ICP-MS analysis {#SEC2-6}
---------------

Exponentially growing HeLa cells were plated at a density of 0.5 × 10^6^ cells/ml in DMEM medium. Ruthenium complexes (final concentration 100 μM) were added to the culture medium and incubated for 1 h at 37°C with 5% CO~2~. After digestion in trypsin−ethylenediaminetetraacetic acid solution, HeLa cells were counted and digested in 60% HNO~3~ at room temperature overnight. Each sample was diluted with Milli-Q H~2~O to obtain 2% HNO~3~ solutions. The standards for calibration were freshly prepared by diluting a RuCl~3~ stock solution with 2% HNO~3~ in Milli-Q H~2~O. The ruthenium concentration in each part was determined by inductively coupled plasma-mass spectrometry (ICP-MS).

Measurement of the binding affinity of Ru--dppz complex with ctDNA and chlorinated phenols {#SEC2-7}
------------------------------------------------------------------------------------------

At least three competing chemical equlibria should be considered, each has its respective binding constant:The binding of \[Ru(bpy)~2~(dppz)\]Cl~2~ to DNA:$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{eqnarray*} &&{\rm{[Ru(bpy}}{{\rm{)}}_{\rm{2}}}{\rm{(dppz)]C}}{{\rm{l}}_{\rm{2}}} \\ && +\,{\rm{ DNA}} \leftrightarrow {{\rm{[Ru(bpy}}{{\rm{)}}_{\rm{2}}}{\rm{(dppz)]}}^{{\rm{2 + }}}}/{\rm{DNA + 2C}}{{\rm{l}}^{\rm{ - }}} \end{eqnarray*}$$\end{document}$$The anion exchange between \[Ru(bpy)~2~(dppz)\]Cl~2~ and chlorophenolate and formation of the ion-pairing complex:$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{eqnarray*} &&{\rm{[Ru(bpy}}{{\rm{)}}_{\rm{2}}}{\rm{(dppz)]C}}{{\rm{l}}_{\rm{2}}} + {\rm{HCP}} {\,-\,{\rm{ OH}}}\\ && \leftrightarrow {{\rm{[Ru(bpy}}{{\rm{)}}_{\rm{2}}}{\rm{(dppz)]}}^{{\rm{2 + }}}}{{\rm{(HCP \,-\, }}{{\rm{O}}^{\rm{ - }}})_2}+{\rm{ 2}}{{\rm{H}}^{\rm{ + }}} \end{eqnarray*}$$\end{document}$$The binding of \[Ru(bpy)~2~(dppz)\]Cl~2~ to bovine serum albumin (BSA)$$\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{eqnarray*} &&{\rm{[Ru(bpy}}{{\rm{)}}_{\rm{2}}}{\rm{(dppz)]C}}{{\rm{l}}_{\rm{2}}}\\ &&{\rm{ + BSA}} \leftrightarrow {{\rm{[Ru(bpy}}{{\rm{)}}_{\rm{2}}}{\rm{(dppz)]}}^{{\rm{2 + }}}}{\rm{/BSA + 2C}}{{\rm{l}}^{\rm{ - }}} \end{eqnarray*}$$\end{document}$$

The absorption titrations of \[Ru(bpy)~2~(dppz)\]Cl~2~ in buffer were performed using a fixed concentration (5 μM) for Ru complex to which increments of the DNA stock solution were added. The intrinsic binding constant *K*~b(Ru-DNA)~, based on the absorption titration, was measured by monitoring the changes in absorption at the MLCT (metal to ligand charge transfer) band with increasing concentration of DNA using the following equation ([@B37]):$$\documentclass[12pt]{minimal}
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Where \[DNA\] is the concentration of added DNA in base pairs, *ϵ*~a~ is the apparent absorption coefficient, which was obtained by calculating *A*~abs~/\[Ru\], and *ϵ*~f~ and *ϵ*~b~ are the extinction coefficients for the free Ru(II) complex and the Ru(II) complex in the fully bound form, respectively. In a plot of \[DNA\]/(*ϵ*~a~-*ϵ*~f~) versus \[DNA\], *K*~b(Ru-DNA)~ is given by the ratio of the slope to the *y* intercept. Binding constant obtained for \[Ru(bpy)~2~(dppz)\]Cl~2~ is 1.5 × 10^6^ M^−1^ ([Supplementary Figure S5](#sup1){ref-type="supplementary-material"}), which is consistent with literature report ([@B9],[@B38]).

Second, the binding affinity of \[Ru(bpy)~2~(dppz)\]Cl~2~ with chlorinated phenols (*K*~b(Ru-HCPs)~) was measured by fluorescence displacement method using ctDNA. As we know, in aqueous solution, Ru--dppz complexes luminesce brightly only when bound to DNA. So Ru--dppz complex can be used as fluorescent probe here due to the light-switching effect upon interaction with DNA. When chemicals compete to bind Ru--dppz complex from DNA, the luminescence of Ru--dppz--DNA will decrease. In the binding solution (10 mM Tris--HCl, pH 7.4), ctDNA and Ru--dppz complex were kept at 100 and 50 μM, respectively. Each chemical was added into the pre-incubated ctDNA/Ru--dppz complex solution with varying concentrations. The fluorescence signal was measured after incubation at RT for 10 min. The 50% inhibitory concentration of each chlorinated phenol (IC~50~) could be obtained from the established competitive titration curve. The dissociation constants and binding constants between each chlorinated phenol and Ru--dppz complex were calculated by the following equation ([@B39]):$$\documentclass[12pt]{minimal}
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Where \[probe\] is the concentration of ctDNA (100 μM), the intrinsic ctDNA binding constant *K*~b(Ru-DNA)~ of \[Ru(bpy)~2~(dppz)\]Cl~2~ is 1.5 × 10^6^ M^−1^. *K*~probe(DNA)~ is the dissociation constant for the intercalation of Ru with ctDNA, thus *K*~probe(DNA)~ = 1/1.5 × 10^6^ M^−1^.

Binding affinity of BSA/Ru--dppz {#SEC2-8}
--------------------------------

BSA/Ru--dppz binding analysis (*K*~b(Ru-BSA)~) was conducted by addition of \[Ru(bpy)~2~(dppz)\]Cl~2~ to BSA (5 μM)/warfarin (10 μM) (*K*~b(warfarin-BSA)~ = 4.5 × 10^4^ M^−1^) solution ([@B34],[@B40]), resulting in a decrease in warfarin fluorescence, the half inhibitory concentration of Ru--dppz (IC~50~) could be obtained from the established competitive titration curve. The dissociation constants and binding constants between BSA and Ru--dppz complex were calculated by the following equations ([4](#M4){ref-type="disp-formula"}) and ([5](#M5){ref-type="disp-formula"}):$$\documentclass[12pt]{minimal}
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Where \[probe\] is the concentration of warfarin, the intrinsic warfarin binding constant *K*~b(warfarin-BSA)~ of BSA is 4.5 × 10^4^ M^−1^. *K*~probe(warfarin)~ is the dissociation constant for the intercalation of warfarin in BSA, here *K*~probe(warfarin)~ = 1/4.5 × 10^4^ M^−1^.

RESULTS AND DISCUSSION {#SEC3}
======================

The most effective nuclear uptake of \[Ru(bpy)~2~(dppz)\]^2\ +^ is facilitated, unexpectedly, by 2,3,4,5-tetrachlorophenol (2,3,4,5-TeCP), rather than the most-highly chlorinated PCP {#SEC3-1}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

As we reported in our recent work, PCP was found to remarkably enhance the cellular and nuclear uptake of cell-impermeable Ru(II)-polypyridyl complexes such as \[Ru(bpy)~2~(dppz)\]Cl~2~ via forming lipophilic and relatively stable ion-pair complexes ([@B33]). However, it remains unclear whether the enhanced cellular and nuclear uptake of \[Ru(bpy)~2~(dppz)\]^2+^ is only limited to PCP, or it is a general phenomenon for other HCPs. So in this study, cellular and nuclear uptake of the model Ru(II)-dppz complex \[Ru(bpy)~2~(dppz)\]Cl~2~ was studied in HeLa cell with three groups of HCPs (six TCPs, three TeCPs and PCP) (Scheme [1](#F1){ref-type="fig"}).

We found that cellular and nuclear uptake of \[Ru(bpy)~2~(dppz)\]^2+^ can be facilitated by all three groups of HCPs in serum-free medium (only cytoplasmic uptake was observed for 2,4,6- and 2,3,6-TCP) as shown by both flow-cytometry and CLSM (Figure [1A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}). Interestingly and unexpectedly, among all these HCPs tested, 2,3,4,5-TeCP was found to be the most effective one in facilitating nuclear uptake of \[Ru(bpy)~2~(dppz)\]^2+^, which is even better than the most-highly chlorinated PCP, and much better than its two other TeCP isomers (2,3,4,6- and 2,3,5,6-TeCP) (Figure [1A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}). Cellular or nuclear uptake efficiency was found to follow the general order by luminescence intensity: 2,3,4,5-TeCP \> 3,4,5-TCP \> 2,3,4-TCP ≈ 2,4,5-TCP ≈ 2,3,5-TCP \> PCP \> 2,3,4,6-TeCP ≈ 2,3,5,6-TeCP \>2,4,6-TCP ≈ 2,3,6-TCP ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). To further determine the cellular and nuclear uptake of Ru by HCPs more accurately, ICP-MS was used to quantify the exact uptake dosage of Ru and similar results were observed as shown in Figure [2](#F3){ref-type="fig"}. More importantly, nuclear uptake of \[Ru(bpy)~2~(dppz)\]^2+^ could also be facilitated by 2,3,4,5-TeCP, 3,4,5-TCP and PCP in full medium containing serum (Figure [1C](#F2){ref-type="fig"} and [Supplementary Figure S2](#sup1){ref-type="supplementary-material"}).

![Cellular uptake of \[Ru(bpy)~2~dppz\]^2+^ is markedly enhanced in the presence of HCPs. (**A**), Flow cytometry analysis of HeLa cells incubated with Ru (100 μM) in the absence or presence of HCPs (300 μM) for 1 h in serum-free medium. Dead cell stain To-Pro-3 (1 μM) was used to exclude or detect dead cells. (**B**) and (**C**), Confocal imaging of HeLa cells incubated with Ru (100 μM) in the absence or presence of HCPs (300 μM) in serum-free medium (B) and in full medium (C).](gkz152fig1){#F2}

![Cellular uptake of \[Ru(bpy)~2~dppz\]^2+^ in the presence of HCPs was determined by ICP-MS. ICP-MS assay for Ru distribution in the cell nucleus and cytoplasm. Cells were treated with Ru (100 μM) in the presence or absence of HCPs (300 μM) for 1 h in serum-free medium. Data represent mean ± S.D. of three independent experiments.](gkz152fig2){#F3}

Then the question is: what are the major physicochemical factors in determining the nuclear uptake of \[Ru(bpy)~2~(dppz)\]^2+^ in the presence of HCPs?

The lipophilicity of HCPs is not correlated with the nuclear uptake of \[Ru(bpy)~2~(dppz)\]^2+^ {#SEC3-2}
-----------------------------------------------------------------------------------------------

It has been shown that the uptake efficiency of Ru--dppz was dependent on the nature of the ancillary ligands, where more hydrophobic ancillary ligands such as DIP promote an increased rate of cellular uptake of Ru ([@B16],[@B17]). According to our recent report, a neutral, lipophilic and relatively stable ion-pairing complex \[Ru(bpy)~2~(dppz)\]^2+^\[PCP^−^\]~2~ was formed between PCP and \[Ru(bpy)~2~(dppz)\]Cl~2~ ([@B33]), where PCP^−^ (pentachlorophenolate anion) acts as a counter-anion that modulates nuclear uptake of \[Ru(bpy)~2~(dppz)\]^2+^ without changing its photophysical property. Therefore, we expected that the uptake efficiency of \[Ru(bpy)~2~(dppz)\]^2+^ might be dependent on the lipophilicity of HCPs (log *K*~ow~ value). But to our surprise, as shown in Table [1](#tbl1){ref-type="table"} and [Supplementary Figure S3](#sup1){ref-type="supplementary-material"}, no obvious correlation was observed between the cellular uptake of \[Ru(bpy)~2~(dppz)\]^2+^ and the lipophilicity of HCPs. This suggests that the lipophilicity of HCPs is probably not a major determining factor for Ru uptake, thus we have to look for other major determining factors.

###### 

Physicochemical properties of HCPs, cellular uptake of \[Ru(bpy)~2~dppz\]^2+^and the binding constant between \[Ru(bpy)~2~dppz\]Cl~2~ and HCPs

  HCPs           p*K*~a~([@B53],[@B54])   log *K*~ow~([@B52])   *K* ~b(Ru-HCPs)~/M^−1^   Ru uptake × 10^−5^(ng/cell)
  -------------- ------------------------ --------------------- ------------------------ -----------------------------
  PCP            4.74                     5.01                  1.49 ± 0.23 × 10^5^      3.71 ± 0.48
  2,3,5,6-TeCP   5.3                      4.90                  2.18 ± 0.26 × 10^4^      2.12 ± 0.08
  2,3,4,6-TeCP   5.22                     4.24                  5.55 ± 0.30 × 10^4^      2.30 ± 0.09
  2,3,4,5-TeCP   5.64                     4.95                  2.94 ± 0.14 × 10^5^      34.2 ± 0.09
  2,4,6-TCP      5.99                     3.69                  1.14 ± 0.15 × 10^4^      1.21 ± 0.06
  2,3,6-TCP      5.90                     3.88                  1.34 ± 0.17 × 10^4^      0.82 ± 0.03
  2,3,5-TCP      6.43                     4.21                  1.35 ± 0.02 × 10^4^      11.6 ± 0.05
  3,4,5-TCP      7.83                     4.39                  \>1.38 ± 0.16 × 10^5^    29.6 ± 0.75
  2,4,5-TCP      7.00                     3.72                  1.00 ± 0.18 × 10^5^      12.2 ± 0.27
  2,3,4-TCP      6.50                     4.07                  1.38 ± 0.28 × 10^5^      13.0 ± 0.53

Data of *K*~b(Ru-HCPs)~ and Ru uptake represent mean ± S.D. of three independent experiments.

p*K*~a~ and log*K*~ow~ values for chlorophenols are from [@B52].

An inverse correlation is observed between nuclear uptake and the lipophilicity of \[Ru(bpy)~2~(dppz)\]^2+^\[HCPs^−^\]~2~ ion-pairing complexes {#SEC3-3}
-----------------------------------------------------------------------------------------------------------------------------------------------

Since lipophilicity of the Ru(II) polypyridyl complexes has been suggested to be a crucial factor in determining Ru cellular uptake ([@B16]), we expected that the lipophilicity of the ion-pairing complexes \[Ru(bpy)~2~(dppz)\]^2+^\[HCPs^−^\]~2~ formed between \[Ru(bpy)~2~(dppz)\]Cl~2~ and HCPs might have a good correlation with Ru uptake. Interestingly and surprisingly, an opposite correlation was observed in partitioning studies of the ion-pairing complexes. As we can see from Figures [3](#F4){ref-type="fig"} and [4](#F5){ref-type="fig"}, the lipophilic ion-pairing complexes formed between \[Ru(bpy)~2~(dppz)\]Cl~2~ and 2,3,4,5-TeCP, or with 3,4,5-TCP are the least hydrophobic ion-pairing complexes among the three TeCP isomers and the six TCP isomers, respectively; but the nuclear uptake of \[Ru(bpy)~2~(dppz)\]^2+^ with 2,3,4,5-TeCP or 3,4,5-TCP are clearly the most effective ones. In clear contrast, although \[Ru(bpy)~2~(dppz)\]Cl~2~ with 2,3,5,6-TeCP and 2,3,4,6-TeCP, or with 2,3,6-TCP and 2,4,6-TCP, are partitioned into the organic phase more effectively, they show much less effective cellular uptake. These results suggest that the least hydrophobic ion-pairing complexes formed between \[Ru(bpy)~2~(dppz)\]Cl~2~ and HCPs will enter the nucleus more effectively than the more hydrophobic ones. In other words, contrary to our expectations, there is an inverse correlation between nuclear uptake and lipophilicity of the ion-pairing complexes \[Ru(bpy)~2~(dppz)\]^2+^\[HCPs^−^\]~2~ in general (Figure [4](#F5){ref-type="fig"}).

![Partitioning studies of \[Ru(bpy)~2~dppz\]Cl~2~ in the presence of HCPs. Partitioning studies of Ru (100 μM) between n-octanol and aqueous phases (Tris--HCl buffer, 10 mM, pH 7.4) in the presence of HCPs with different ratios were measured. Data represent mean ± S.D. of three independent experiments.](gkz152fig3){#F4}

![Correlations of nuclear uptake of \[Ru(bpy)~2~dppz\]^2+^ in the presence of HCPs with binding stability and hydrophobicity of the formed ion-pairing complexes \[Ru(bpy)~2~(dppz)\]^2+^\[HCPs^−^\]~2~. (**A**), (red bar) nuclear uptake of Ru (×10^−5^ ng/cell) was determined by ICP-MS; (green bar) binding ability (×10^4^ M^−1^) was measured by fluorescence displacement method; (blue bar) The lipophilicity of the formed ion-pairing complexes were determined by partitioning studies (data obtained by absorption intensity (Ru/HCPs = 1:10) in n-octanol phase ×10). (**B**), correlation between nuclear uptake and binding constant (positive correlation)/lipophilicity (inverse correlation) of the formed ion-pairing complexes. Data represent mean ± S.D. of three independent experiments.](gkz152fig4){#F5}

Our above findings in live-cells are consistent with what Lincoln's group reported previously in fixed cells ([@B22],[@B41]). They found that the Ru(II) complexes by substituting with alkyl ether chains of increasing length exhibited distinctly different cellular localization in fixed cells (It should be noted, however, that no nuclear uptake was observed with these ruthenium complexes in live cells) due to their different lipophilicity: The least lipophilic complex enters inside the nucleus to stain DNA, while the most lipophilic complex preferentially stains membrane-rich parts of the cell. Therefore, for metal complexes to enter the cell nucleus, the lipophilicity of the complex has to fall within an optimal window, otherwise the complex either becomes too insoluble in aqueous media and can't get through the cell membrane for low lipophilicity, or is trapped within the membrane or in organelles in the cytoplasm if it is highly lipophilic. Based on the above considerations, we speculate that nuclear uptake of cationic metal complexes may favor toward those with lower lipophilicity, provided they can first penetrate through the cytoplasmic membrane. Therefore, there should be other crucial physiochemical parameters in determining nuclear uptake of the cationic metal complexes via ion-pairing with the counter-anions.

The enhanced nuclear uptake of \[Ru(bpy)~2~(dppz)\]^2+^ by HCPs is positively correlated with the binding stability of the ion-pairing complexes formed between \[Ru(bpy)~2~(dppz)\]Cl~2~ and HCPs {#SEC3-4}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

After considering the lipophilicity for both HCPs and the formed ion-pairing complexes, we then investigated another potential important factor crucial for the nuclear uptake, the binding stability (*K*~b(Ru-HCPs)~) between \[Ru(bpy)~2~(dppz)\]Cl~2~ and HCPs.

As we reported recently, ion pairs were found to be formed between PCP and Ru(II) complexes, which were held together mainly by Coulombic forces ([@B33]). For Ru(II) complex, to escape being trapped by protein and membrane structures in the cytoplasm to get into the nucleus, ion pair formed with HCPs should be neutral and stable enough. In other word, the binding affinity between HCPs and Ru(II) complex should be strong enough to keep the ion-pairing complex as a whole before reaching nucleus. Therefore, we speculate that the binding affinity between HCPs and Ru(II) complex should be another critical physicochemical factor in determining cellular uptake and distribution of Ru(II) complex. To test the above hypothesis, the binding constants (*K*~b(Ru-HCPs)~) between \[Ru(bpy)~2~(dppz)\]Cl~2~ and HCPs were measured by fluorescence displacement method ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}, for details, see 'Materials and Methods' section).

As expected, the nuclear uptake of \[Ru(bpy)~2~(dppz)\]^2+^ by HCPs was found to be positively correlated with the binding ability between \[Ru(bpy)~2~(dppz)\]Cl~2~ and HCPs (Figure [4](#F5){ref-type="fig"} and Table [1](#tbl1){ref-type="table"}). Interestingly, in the competition experiment, we found that the four HCPs (including 2,3,4,5-TeCP, 3,4,5-, 2,3,4- and 2,4,5-TCP) showing the high efficiency in facilitating nuclear uptake could also cause blue shift of Ru emission spectrum in the DNA system when the concentrations of the four HCPs are relatively high ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}), which indicate that new ternary complexes are probably formed among \[Ru(bpy)~2~(dppz)\]Cl~2~, DNA and the four HCPs.

Then the question is what is the possible underlying molecular basis for the different Ru(II)-binding affinity for these chlorophenol isomers (TeCPs; TCPs)?

As we recently reported, a neutral, lipophilic and relatively stable ion-pairing complex was formed between Ru(II) complex and PCP with a 1:2 stoichiometry as demonstrated by single-crystal X-ray diffraction ([@B33]). The ion-pairing complex has been suggested to belong to the outer sphere contact ion-pair ([@B42]), in which the coordinatively saturated first coordination sphere of the cation (Ru(II) complex) is no longer accessible to the anion (pentachlorophenlate), and consequently, the anion is relegated to the second coordination sphere, interacting with the cation through electrostatic and other weak forces such as aromatic pi stacking, H-bonding, δ-δ, CH-δ, etc ([@B42]). According to the crystal structure, solvent water molecules were also found to interact with the phenolic hydroxyl group by forming hydrogen bond, which appears to be one of the major forces in holding the ion-pairing complex together ([@B33]).

Hence, based on the chemical structures of chlorophenol isomers, the strength of the binding affinity (*K*~b(Ru-HCPs)~) between Ru(II) complex and HCPs might be determined by the basic physicochemical properties of chlorophenols ([@B47]), which include the electron-withdrawing properties of Cl atoms and the steric hindrance effects as listed below: (i) electron-withdrawing Cl-substituents at both ortho-positions (2- and 6-positions) reduce the π -electron density in aromatic ring, and as a result, leading to weak electrostatic forces; (ii) Cl-substituents at both ortho-positions (2- and 6-positions) enhance steric hindrance effects, and reduce chances for solvent water molecules interacting with the phenolic hydroxyl group. For the three TeCP isomers, their Ru(II)-binding affinity strength follows the order: 2,3,4,5-TeCP \>\> 2,3,4,6-TeCP \> 2,3,5,6-TeCP. Comparing with 2,3,4,5-TeCP with only one Cl atom at 2-position, both Cl-substituents at two ortho-positions (2- and 6-positions) for 2,3,4,6-TeCP and 2,3,5,6-TeCP will enhance the steric hindrance effects; on the other hand, the electron withdrawing Cl-substitution groups at two ortho-positions also reduce the π-electron density in the aromatic ring, which, consequently, weakens the electrostatic forces formed between solvent H~2~O molecules and the phenolic hydroxyl group of HCP; While only one Cl-substituent in 2-position for 2,3,4,5-TeCP makes a higher π-electron density in the aromatic ring, thus leading to a relatively stronger electrostatic force. Similar explanations may also be applied to the six TCP isomers: 2,3,6-TCP, 2,4,6-TCP with Cl-substituents at two ortho-positions (2- and 6-positions) have both stronger steric hindrance effects and lower π-electron density, which contribute to their lower Ru(II)-binding constant *K* values for the two TCPs than that for the other four TCPs (Table [1](#tbl1){ref-type="table"}).

The binding affinity (K~b(Ru-BSA)~) between \[Ru(bpy)~2~(dppz)\]Cl~2~ and BSA is determined by fluorescence displacement method {#SEC3-5}
-------------------------------------------------------------------------------------------------------------------------------

Since Ru luminescence was also observed in the cytoplasm, which is probably caused by interaction with cytoplasmic proteins ([@B40],[@B51]), we further studied the binding affinity between \[Ru(bpy)~2~(dppz)\]Cl~2~ and BSA, a structural homologue of human serum albumin, HSA), by fluorescence displacement method, where warfarin was used as the fluorescent probe (for details, see 'Materials and Methods' section). As shown in [Supplementary Figure S5](#sup1){ref-type="supplementary-material"}, interactions between \[Ru(bpy)~2~(dppz)\]Cl~2~ and BSA indeed exist, and the binding constant (*K*~b(Ru-BSA)~) between \[Ru(bpy)~2~(dppz)\]Cl~2~ and BSA was determined to be 9.78 × 10^4^ M^−1^, which is much higher than the binding constants (*K*~b(Ru-HCPs)~) of the ion-pairing complexes formed between \[Ru(bpy)~2~(dppz)\]Cl~2~ and 2,4,6-TCP or 2,3,6-TCP (1.14 × 10^4^ M^−1^, 1.34 × 10^4^ M^−1^, respectively). The relatively weak Ru(II)-binding affinity for 2,4,6-TCP, 2,3,6-TCP and 2,3,5-TeCP makes the ion-pairs formed not strong enough to compete with protein or even membrane components in the cytoplasm (or in full medium containing serum), thus leading to poor nuclear uptake of \[Ru(bpy)~2~(dppz)\]^2+^. Analogous effects were observed for 2,3,4,6-TeCP or 2,3,5,6-TeCP. In clear contrast, the relatively strong Ru(II)-binding affinity for 2,3,4,5-TeCP (2.94 × 10^5^ M^−1^) and 3,4,5-TCP (\>1.38 × 10^5^ M^−1^) makes the ion-pairing complexes formed strong enough to compete with cytoplasmic components, resulting in efficient nuclear uptake of \[Ru(bpy)~2~(dppz)\]^2+^ even in full medium. Therefore, strong binding affinity (*K*~b(Ru-HCPs)~) between \[Ru(bpy)~2~(dppz)\]Cl~2~ and HCPs is assumed to be one of the most important factors in determining whether \[Ru(bpy)~2~(dppz)\]Cl~2~/HCPs could make its way through to the nucleus. These results further confirm that the ion-pairing complex formed should be neutral and stable enough to escape being trapped by protein and membrane structures in the cytoplasm or in full medium to enter the nucleus.

The enhanced nuclear uptake efficiency of \[Ru(bpy)~2~(dppz)\]^2+^ by HCPs is determined by a combination of both of the binding affinity and the lipophilicity of the formed ion-pairing complex {#SEC3-6}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

After considering all the potential factors, the uptake efficiency of \[Ru(bpy)~2~(dppz)\]^2+^ by all three groups of HCPs (TCPs, TeCPs and PCP) can be well explained by the combination effects of both the binding affinity and the lipophilicity of the formed ion-pairing complexes. In general, (i) the cellular uptake efficiency follows the following order: 2,3,4,5-TeCP, 3,4,5-TCP \> 2,3,4-TCP, 2,4,5-TCP, 2,3,5-TCP \> PCP \> 2,3,4,6-TeCP, 2,3,5,6-TeCP \> 2,4,6-TCP, 2,3,6-TCP; (ii) the binding affinity of the ion-pairing complexes follows the similar order: 2,3,4,5-TeCP, PCP, 3,4,5-TCP \> 2,3,4-TCP \> 2,4,5-TCP \> 2,3,4,6-TeCP \> 2,3,5,6-TeCP \> 2,3,5-TCP \> 2,3,6-TCP \> 2,4,6-TCP; while in contrast, (iii) the lipophilicity of the ion-pairing complexes follows an opposite order: 2,3,4,5-TeCP \< 2,3,4,6-TeCP \< 2,3,5,6-TeCP, PCP; 3,4,5-TCP \< 2,3,4-TCP \< 2,4,5-TCP \< 2,3,5-TCP \< 2,4,6-TCP \< 2,3,6-TCP (Table [1](#tbl1){ref-type="table"} and Figure [4](#F5){ref-type="fig"}). These results clearly demonstrate that the nuclear uptake of \[Ru(bpy)~2~(dppz)\]^2+^\[HCPs^−^\]~2~ is positively correlated with their binding ability, however, inversely correlated with their lipophilicity. So the enhanced nuclear uptake efficiency of \[Ru(bpy)~2~(dppz)\]^2+^ by HCPs is, to a large extent, determined by a combination effect of their binding affinity and the lipophilicity of the ion-pairing complexes \[Ru(bpy)~2~(dppz)\]^2+^\[HCPs^−^\]~2~.

For 2,3,4,5-TeCP, the highest Ru(II)-binding constant value (2.94 × 10^5^ M^−1^), along with the low lipophilicity of the formed ion-pairing complex \[Ru(bpy)~2~dppz\]^2+^\[2,3,4,5-TeCP^−^\]~2~ together contributes to its most effective nuclear uptake of \[Ru(bpy)~2~dppz\]^2+^. In contrast, for 2,4,6-TCP and 2,3,6-TCP, their high lipophilicity of formed ion-pairs would make them easily be trapped in the lipid membrane structures or proteins in cytoplasm, and their lowest Ru(II)-binding constant *K* values (1.14 × 10^4^ M^−1^ and 1.34 × 10^4^ M^−1^, respectively) among all HCPs tested would let them be readily dissociated in the environment full of competing bio-molecules. As for PCP, although its Ru(II)-binding affinity (1.49 × 10^5^ M^−1^) is relatively high, the ion-pairing complex \[Ru(bpy)~2~(dppz)\]^2+^\[PCP^−^\]~2~ formed is the most lipophilic one among all HCPs tested as we can see in the partitioning study (Figure [3](#F4){ref-type="fig"}). The property with the highest hydrophobicity, on one hand, makes it too insoluble in aqueous media: much more precipitation was observed when \[Ru(bpy)~2~dppz\]Cl~2~ was mixed together with PCP than that with other HCPs ([Supplementary Figure S6](#sup1){ref-type="supplementary-material"}); on the other hand, it might also be much easily trapped within the lipid bi-layer membrane or organelle membrane structures in the cytoplasm. So all the above results could explain the phenomenon that Ru uptake efficiency for PCP is much poorer than for 2,3,4,5-TeCP and even poorer than that for the four TCPs (3,4,5-TCP, 2,3,5-TCP, 2,3,4-TCP, 2,4,5-TCP). The relatively poor Ru uptake efficiency for 2,3,4,6-TeCP and 2,3,5,6-TeCP can also attribute to their relatively high hydrophobicity and relatively low binding affinity after forming ion-pairs with \[Ru(bpy)~2~dppz\]Cl~2~.

Above all, the binding affinity and the lipophilicity of the formed ion-pairing complexes are two major physicochemical factors in determining nuclear uptake efficiency of Ru: the higher Ru-binding affinity, the better Ru uptake efficiency; while in contrast, the higher lipophilicity of the formed ion-pairing complexes leads to the poorer Ru uptake efficiency.

CONCLUSIONS {#SEC4}
===========

In conclusion, we have shown that the Ru(II)-dppz polypyridyl 'light switch' complex \[Ru(bpy)~2~dppz\]Cl~2~ was readily taken up by cells and preferentially localized in the nucleus in the presence of three groups of HCPs (TCPs, TeCPs and PCP), via forming neutral, lipophilic and relatively stable ion-pair complexes. HCPs here act as counter-anions modulating cellular and nuclear uptake of Ru(II)-dppz complexes yet without changing the DNA 'light switch' nature of Ru(II) complexes. The detailed studies demonstrate that both the binding affinity and lipophilicity of the formed ion-pairing complexes are critical physicochemical factors in determining Ru nuclear uptake efficiency by HCPs. The Ru uptake is positively correlated with their binding ability, but inversely correlated with the lipophilicity of the ion-pairing complexes formed. These findings should provide important new perspectives for future investigations on delivering other bio-active metal complexes into their intended cellular targets via ion-pairing method, which is a conceptual breakthrough from the traditional delivering methods.
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